Corrigendum to “Evaluation of commercial quadrivalent foot-and-mouth disease vaccines against east African virus strains reveals limited immunogenicity and duration of protection” [Vaccine 42 (1–12) (2024) 126325]
Titel:
Corrigendum to “Evaluation of commercial quadrivalent foot-and-mouth disease vaccines against east African virus strains reveals limited immunogenicity and duration of protection” [Vaccine 42 (1–12) (2024) 126325]
Auteur:
Kerfua, Susan D. Haydon, Daniel T. Wilsden, Ginette Ludi, Anna King, Donald P. Okurut, Rose Ademun Atim, Stella Dhikusooka, Moses T. Kyakuwa, Ivan Motta, Paolo Paton, David J.